Moisture Testing and Its Impact on ODF & Tablet Stability

Moisture тестирование and Its Impact on ОРД таблетка Stability

Introduction
Throughout the lifecycle of solid dosage forms—during production, transportation, and storage—moisture content plays a critical role in determining product stability. Excess moisture may cause softening, deformation, or microbial risks, while insufficient moisture can lead to brittleness, compromising appearance and dosage uniformity. Moisture тестирование is therefore essential not only for in-process контроль качества, but also for long-term stability assurance.

1. The Link Between Moisture and Storage Stability

Интересует фармацевтическое тестовое оборудование?
Свяжитесь с Huanghai для получения спецификаций, технической консультации и расценок. Запросить расценки →

  • Sensitivity to Temperature and Humidity: ODFs and таблетки are prone to moisture uptake and degradation in high-humidity environments.
  • Packaging Compatibility: Moisture barrier performance varies between packaging types such as foil, bottles, or pouches—making moisture тестирование vital for validation.
  • Shelf-Life Evaluation: High or fluctuating moisture levels can directly shorten product shelf life and impact regulatory acceptance.

2. Common Challenges in the Industry

  • Single-Point тестирование: Many manufacturers only тест moisture at the time of release, ignoring dynamic changes during storage.
  • Packaging Neglect: Moisture validation often focuses on the final product, omitting packaging and simulated storage condition тестирование.
  • Time-Consuming Methods: Traditional oven-drying techniques are inefficient and unsuited for fast-paced batch environments.

3. Industry Trends

  • Rapid Moisture анализ: Electronic moisture analyzers are increasingly replacing traditional oven methods for higher efficiency.
  • Expanded Stability Studies: Companies are aligning with ICH guidelines to integrate moisture тестирование into accelerated and long-term studies.
  • End-to-End контроль качества: Moisture анализ is now being extended to raw materials and intermediates, not just final products.

4. HUANGHAI’s Moisture тестирование Solutions

  • Our HY-310 Electronic анализатор влажности supports тестирование of ОРД films, таблетки, and powders.
  • Offers fast detection, easy operation, and suitability for large-scale контроль качества and stability trials.
  • Delivers high accuracy in соответствие with pharmacopoeial стандарты, minimizing risks during registration and export.

👉 Recommended Product:
HY-310 Electronic анализатор влажности

Conclusion

Moisture тестирование is a small but vital step in ensuring the long-term quality of solid dosage forms. By adopting fast and reliable moisture тестирование technologies, фармацевтический and добавка manufacturers can effectively predict shelf-life, mitigate regulatory risks, and enhance market competitiveness.

Полный перечень сертификатов и стандартов соответствия нашего оборудования доступен на странице Сертификаты и соответствие.


Frequently Asked Questions

Q: What is the difference between an ОРД плёнка and a трансдермальный пластырь?

A: Oral Dissolving Films (ОРД) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar растворитель-cast плёнка покрытие processes. Huanghai's MJ150 ОРД машина supports both applications on a single platform with approximately 2 working days of changeover time.

Q: What production output can I expect from a Huanghai ОРД машина?

A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either машина with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.

Q: What drying technology does Huanghai use for ОРД production?

A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform плёнка thickness, reduced edge curl, and better АФИ distribution across the плёнка web. An optional far-infrared heating module adds 20–30% drying efficiency for растворитель-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ОРД оборудование supplier to Sinopharm, Shanghai фарма, and Fosun фарма.

Q: What are the GMP требования for ОРД production оборудование?

A: ОРД производство оборудование must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent стандарты (EU GMP Annex 1, ChGMP) for other markets. Key требования: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; данные integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ОРД машины meet these стандарты—all product contact surfaces use фармацевтический-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP соответствие documentation.

Q: Can Huanghai машины produce stripe-coated or multi-formula ОРД films?

A: Yes. Huanghai holds a patent for multi-formula stripe покрытие (Patent CN117323228A), enabling two different АФИ formulations to be applied side-by-side in a single покрытие pass. This eliminates the need for multiple покрытие/drying cycles when producing combination-drug ОРД products. Competitors require manual multi-layer покрытие with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-АФИ ODFs for cardiovascular or CNS indications) where покрытие efficiency directly impacts production economics.

Вернуться к блогу

Свяжитесь с нами